Pressemitteilungen

百多力宣布第一位病人已录入在中国开展的 BIOFLOW-VI临床研究中

, Medical Technology

百多力,心脏与血管内医疗技术的领导者今天­宣布,第一位病人已经录入到在中国开展的B­IOFLOW-VI临床研究中了。研究的结果将会被用于进­一步证明百多力的Orsiro混合药物洗脱­支架(DES)的安全性和疗效并且争取中国­的市场认可。第一例植入的患者由BIOFL­OW-VI临床协调调查员、中国北京阜外医院的杨­跃进博士成功实施。 BIOFLOW-VI是一种有前瞻性的、多中心的、随机的、­对照的临床试验。这项研究计划在中国的15­个临床试验点共注册440名患者。符合条件­的冠心病患者将按1:1的比例随机接受Or­siro...

BIOTRONIK Announces First Patient Enrolled in BIOFLOW-VI Clinical Study in China

, Medical Technology

BIOTRONIK, a leading manufacturer of cardio- and endovascular medical technology, announced today that the first patient has been enrolled in...

ESC Congress 2015: BIOTRONIK Announces CE Approval and Pilot Study Results for BioMonitor 2

, Medical Technology

BIOTRONIK, a leading manufacturer of cardio- and endovascular medical technology, today announced CE approval and the results of a pilot study...

ESC-Kongress 2015: BIOTRONIK gibt CE-Zulassung und Ergebnisse der Pilotstudie zum BioMonitor 2 bekannt

, Medical Technology

BIOTRONIK, ein führender Hersteller kardio- und endovaskulärer Medizintechnik, gab heute die CE-Zulassung und die Ergebnisse der Pilotstudie...

BIOTRONIK Implantate zur Herzinsuffizienztherapie nun für Ganzkörper-MRTs zugelassen

, Medical Technology

BIOTRONIK, der weltweit führende Hersteller von MRT-tauglichen Herzimplantaten, hat die CE-Zulassung seiner beiden aktuellsten Generationen an...

BIOTRONIK presents its CRT-Ds Approved for Full-Body MRI Scanning at ESC Congress 2015

, Medical Technology

BIOTRONIK, the world’s leading manufacturer of MR conditional cardiac devices, has announced CE approval for full-body MRI scanning for its last...

BIOTRONIK Announces First Enrollments in the BIO|GUARD-MI Study

, Medical Technology

BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced today the first enrollments in the BIO|GUARD-MI1 study. The...

BIOTRONIK gibt Aufnahme der ersten Patienten in die BIO|GUARD-MI-Studie bekannt

, Medical Technology

BIOTRONIK, ein führender Hersteller kardiovaskulärer Medizintechnik, hat heute die Aufnahme der ersten Patienten in die Studie BIO|GUARD-MI bekanntgegeben....

Компания BIOTRONIK объявила о начале первого исследования по оценке важности наличия функции дефибриллятора в устройстве после замены им эксплантированного CRT-D

, Research / Development

Компания BIOTRONIK -ведущий производитель в области кардиоваскулярных медицинских технологий, объявила сегодня, что первый пациент был включен...

BIOTRONIK Announces Start of First Study to Assess Relevance of Defibrillator Back-Up after CRT-D Replacement

, Research / Development

BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced today that the first patient has been enrolled in the BioCONTINUE...

BIOTRONIK Becomes First Manufacturer of Single- and Dual-Chamber Pacemakers and ICDs Approved for Use in 3 Tesla MRI Scans Worldwide

, Medical Technology

BIOTRONIK, the world's leader in ProMRI® cardiac devices, has announced CE approval of 3 tesla (T) MRI scanning with exclusion zone for its two...

Heart Failure Patients Now Have Expanded Therapy Options and Unique Pacing Features with New BIOTRONIK CRT-D Device

, Medical Technology

BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced today that the first patients have been successfully implanted...

Le CardioMessenger Smart, nouveau transmetteur du système de Télécardiologie - BIOTRONIK, améliore la sécurité des patients

, Medical Technology

Ce nouveau transmetteur permet un ajustement précoce des traitements chez les patients porteurs de stimulateurs cardiaques, de défibrillateurs...

BIOTRONIK Announces Start of Pioneering BIOWOMEN Study

, Medical Technology

BIOTRONIK, a leading manufacturer of cardio- and endovascular medical devices, announced today the first patient enrolment in its BIOWOMEN clinical...

Zukunftweisende BIOWOMEN-Studie von BIOTRONIK mit erster Patientin gestartet

, Medical Technology

BIOTRONIK, ein führender Hersteller kardio- und endovaskulärer Medizintechnik, gab heute den Einschluss der ersten Patientin in die BIOWOMEN-Studie...

Media

Loading data, please wait...
Loading data, please wait...
Loading data, please wait...
Loading data, please wait...
BIOTRONIK
Woermannkehre 1
D - 12359 Berlin



Ansprechpartner

Frau Manuela Schildwächter


Communications & PR Manager
BIOTRONIK SE & Co. KG

Telefon +49 (30) 689051414


Frau Teresa McGowan


Freelance Communications & PR Manager

Telefon +49 (30) 68905-1416
Fax +49 (30) 6890596-1466


alle Ansprechpartner
Disclaimer